Self-reported prevalence and factors associated with nonadherence with glaucoma medications in veteran outpatients

American Journal Geriatric Pharmacotherapy

Volumn 7, Issue 2, 2009, Pages 67-73

  Sleath, Betsy ^a   Ballinger, Rex ^b   Covert, David ^c   Robin, Alan L ^d,e   Byrd, John E ^a   Tudor, Gail ^f  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ALCON RESEARCH LTD   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HUSSON UNIVERSITY   (United States)

Author keywords

adherence; glaucoma; patient reported difficulties; veterans

Indexed keywords

ANTIGLAUCOMA AGENT; EYE DROPS;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; DRUG SELF ADMINISTRATION; FEMALE; GLAUCOMA; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; OUTPATIENT CARE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE DIFFERENCE; SELF REPORT; VETERAN;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLAUCOMA; HEALTH CARE SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; OUTPATIENTS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; VETERANS;

EID: 65549141529     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2009.04.001     Document Type: Article

References (40)

1. Congdon N., O'Colmain B., Klaver C.C., et al., the Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 122 (2004) 477-485
2. Sommer A., Tielsch J.M., Katz J., et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 325 (1991) 1412-1417
3. Tielsch J.M., Sommer A., Katz J., et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 266 (1991) 369-374
4. Ostermann J., Sloan F.A., Herndon L., and Lee P.P. Racial differences in glaucoma care: The longitudinal pattern of care. Arch Ophthalmol. 123 (2005) 1693-1698
5. Leske M.C., Connell A.M., and Kehoe R. A pilot project of glaucoma in Barbados. Br J Ophthalmol. 73 (1989) 365-369
6. Mason R.P., Kosoko O., Wilson M.R., et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology. 96 (1989) 1363-1368
7. Boland M.V., and Quigley H.A. Risk factors and open-angle glaucoma: Classification and application. J Glaucoma. 16 (2007) 406-418
8. The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 130 (2000) 429-440
9. Kass M.A., Heur D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 120 (2002) 701-713 discussion
10. Kass M.A., Heur D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 120 (2002) 829-930
11. Heijl A., Leske M.C., Bengtsson B., et al., the Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 120 (2002) 1268-1279
12. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 126 (1998) 498-505
13. Lichter P.R., Musch D.C., Gillespie B.W., et al., the Collaborative Initial Glaucoma Treatment Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 108 (2001) 1943-1953
14. Higginbotham E.J., Schuman J.S., Goldberg I., et al., the Bimatoprost Study Groups 1 and 2. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol. 120 (2002) 1286-1293
15. Camras C.B., Alm A., Watson P., and Stjernschantz J. Latano-prost, a prostaglandin analog, for glaucoma therapy. Ef-ficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Group. Ophthalmology. 103 (1996) 1916-1924
16. Meichenbaum D., and Turk D.C. Facilitating Treatment Adherence: A Practitioners' Guidebook (1987), Plenum Press, New York, NY
17. DiMatteo M.R. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care. 42 (2004) 200-209
18. Kass M.A., Gordon M., Morley R.E., et al. Compliance with topical timolol treatment. Am J Ophthalmol. 103 (1987) 188-193
19. Gurwitz J.H., Glynn R.J., Monanc M., et al. Treatment for glaucoma: Adherence by the elderly. Am J Public Health. 83 (1993) 711-716
20. Robin A.L., and Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?. Ophthalmology. 112 (2005) 863-868
21. Patel S.C., and Spaeth G.L. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 26 (1995) 233-236
22. Sleath B., Robin A.L., Covert D., et al. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 113 (2006) 431-436
23. Muir K.W., Santiago-Turla C., Stinnett S.S., et al. Health literacy and adherence to glaucoma thcrapv. Am J Ophthalmol. 142 (2006) 223-226
24. Taylor S.A., Galbraith S.M., and Mills R.P. Causes of noncompliance with drug regimens in glaucoma patients: A qualitative study. J Ocul Pharmacol Ther. 18 (2002) 401-409
25. Winfield A.J., Jessiman D., Williams A., and Esakowitz L. A study of the causes of non-compliance bv patients prescribed eye drops. Br J Ophthalmol. 74 (1990) 477-480
26. Krishnan J.A., Diette G.B., and Rand C.S. Disparities in outcomes from chronic disease. BMJ. 323 (2001) 950
27. Melfi C.A., Croghan T.W., Hanna M.P., and Robinson R.L. Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry. 61 (2000) 16-21
28. Wells K.B., Kamberg C., Brook R., et al. Health status, so-ciodemographic factors, and the use of prescribed psychotropic drugs. Med Care. 23 (1985) 1295-1306
29. Sleath B., Clipp E., Doyle M., et al. Medication use among African depressed black and white caregivers of veterans with dementia. J Am Geriatr Soc. 53 (2005) 397-404
30. Svarstad B.L., Chewning B.A., Sleath B.L., and Claesson C. The Brief Medication Questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Edue Couns. 37 (1999) 113-124
31. Hanlon J.T., Fillenbaum G.G., Burchett B., et al. Drug-use patterns among black and nonblack community-dwelling elderly. Ann Pbarmacother. 26 (1992) 679-685
32. Fillenbaum G.G., Horner R.D., Hanlon J.T., et al. Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population. J Clin Epidemiol. 49 (1996) 587-593
33. Krishnan J.A., Diette G.B., Skinner E.A., et al. Race and sex differences in consistency of care with national asthma guidelines in managed care organizations. Arch Intern Med. 161 (2001) 1660-1668
34. Sleath B., Thorpe J., Landerman L.R., et al. Medication use among black and white caregivers of older male veterans with dementia. Am J Geriatr Pbarmacother. 2 (2004) 133-140
35. Wells K.B., Goldberg G., Brooks R., and Leake B. Management of patients on psychotropic drugs in primary care clinics. Med Care. 26 (1988) 645-656
36. Sharkness C.M., and Snow D.A. The patient's view of hypertension and compliance. Am J Prev Med. 8 (1992) 141-146
37. Monane M., Bohn R.L., Gurwitz J.H., et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: The roles of age, gender, and race. Am J Public Health. 86 (1996) 1805-1808
38. Gross R., Zhang Y., and Grossberg R. Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf. 14 (2005) 789-793
39. Motheral B.R., and Heinle S.M. Predictors of satisfaction of health plan members with prescription drug benefits. Am J Health Syst Pharm. 61 (2004) 1007-1014
40. Kass M.A., Meltzer D.W., Gordon M., et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 101 (1986) 515-523